Advertisement
Canada markets close in 25 minutes

  • S&P/TSX

    22,012.99
    +141.03 (+0.64%)
     

  • S&P 500

    5,070.64
    +60.04 (+1.20%)
     

  • DOW

    38,498.42
    +258.44 (+0.68%)
     

  • CAD/USD

    0.7320
    +0.0019 (+0.26%)
     

  • CRUDE OIL

    83.35
    +1.45 (+1.77%)
     

  • Bitcoin CAD

    90,870.01
    +246.54 (+0.27%)
     

  • CMC Crypto 200

    1,433.32
    +18.56 (+1.31%)
     

  • GOLD FUTURES

    2,338.30
    -8.10 (-0.35%)
     

  • RUSSELL 2000

    2,005.42
    +37.95 (+1.93%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ

    15,708.67
    +257.37 (+1.67%)
     

  • VOLATILITY

    15.79
    -1.15 (-6.78%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Why Inovio Pharmaceuticals Is Gaining Today

Alex Carchidi, The Motley Fool
·2 min read

Inovio Pharmaceuticals' (NASDAQ: INO) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its operations to conserve cash. The biotech will lay off 18% of its full-time employees while additionally reducing its contractor head count by a massive 86%. Inovio also announced the appointment of a new chief medical officer, Dr. Michael Sumner, which might be another contributing factor to the gain of its stock today.

Continue reading